PharmaLogic Holdings Corp., a contract development and manufacturing organisation (CDMO) and radiopharmacy solutions provider, has announced the official opening of its new radiopharmaceutical production and research facility in Salt Lake City, Utah. The facility is designed to support the delivery
FibroBiologics and Charles River Laboratories have entered a master services agreement to develop and manufacture FibroBiologics’ fibroblast-based therapeutic product, CYWC628. This product is set to be used in a diabetic foot ulcer (DFU) clinical trial scheduled to begin in 2025.
Jon Reed, Head of Strategic Business Planning at Recipharm, recently shared insights into the CDMO’s latest innovations and market strategies. Speaking to the PharmaSource podcast at CPHI Milan, Jon explains how Recipharm, one of the largest CDMOs in the industry
Dexter Tjoa, CEO of Tjoapack, recently shared insights into the company’s evolution from a small Dutch contract packaging organisation (CPO) to a global player in pharmaceutical packaging. Celebrating its 35th anniversary, Tjoapack has strategically expanded its operations, most notably with
Eric Kaneps, Vice President of Sales & Marketing at Renaissance Lakewood, recently shared insights into the company’s expansion and focus on nasal spray technology. Speaking to PharmaSource at CPHI Milan, he explained that the US-based CDMO has completed a significant
Peter Bullard, Senior Vice President of Manufacturing at NovaCina, recently shared insights into the Australian CDMO’s unique position in the global pharmaceutical market. Speaking to PharmaSource at CPHI Milan he explains how despite being only 18 months old, NovaCina boasts
Speaking at CPHI Milan, Craig Cox, Vice President of Global Sales, Bioprocessing at Ecolab, shared insights into the company’s role in supporting drug development and manufacturing. “Ecolab supports drug development within the process, including chromatography resins for biologic purification and
SpectronRx, based in Indianapolis, is expanding its operations by establishing a new radiolabeling facility in Belgium. The company announced a binding agreement to build the plant at the Belgian Nuclear Research Center (SCK CEN) in Mol. The construction is expected
Cambrex, a global contract development and manufacturing organisation (CDMO), has announced the opening of a new cGMP stability storage facility in Durham, North Carolina. The facility, operated by its subsidiary Q1 Scientific, expands the company’s capability to provide temperature-controlled storage
SMC Ltd., a medical device contract manufacturer, has announced a significant expansion of its facility in Devens, Massachusetts. The 160,000 sq. ft. extension will introduce three new ISO 8 cleanrooms and a cold chain storage warehouse maintained at 2-8 degrees
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
